The article aims to provide basic information to customers about the concept of gastroesophageal reflux disease, disease symptoms, risks brought by the disease, prevention and treatment.

Barrett's esophagus is a gastrointestinal disease, common in people with long-term gastroesophageal reflux disease. Chronic reflux of acid from the stomach into the lower esophagus. Barrett's esophagus can lead to esophageal cancer.

Occurrence of bile reflux is often associated with disturbances in the functioning of the pyloric valve and the esophageal sphincter. Symptoms of bile reflux are similar to those of gastroesophageal reflux such as upper abdominal pain, heartburn, vomiting, and nausea.

Bile reflux is difficult to distinguish from acid reflux, requiring additional tests to confirm. The disease is treated with drugs and surgery in cases where there is a risk of cancer progression.

Gastroesophageal reflux and Barrett's esophagus are diseases with the same etiology and pathogenesis. In fact, Barrett's esophagus is a complication of gastroesophageal reflux because it is not detected and treated in time.

Gastroesophageal reflux disease is classified into 5 levels, 0, A, B, C, D. Detecting the disease at an early stage, especially grade A, makes the treatment more convenient and brings better results. more effective, reduce the risk of complications.

People with GERD experience uncomfortable symptoms or damage to the esophagus as a result of acid reflux. Symptoms of GERD can include heartburn, regurgitation, and difficulty swallowing or pain when swallowing.

Hi doctor. I went to the doctor for Barrett's esophagus, I want to know if the transition from Barrett's esophagus to esophageal cancer is fast? The doctor performed an endoscopy and took medicine but did not take a biopsy.

Hello doctor, my mother went to the doctor and it was concluded that Barrett's esophagus is short and has a high risk of cancer. So the doctor asked me, is Barrett's esophagus a dangerous cancer risk?

Since entering the market, proton pump inhibitors (PPIs) have revolutionized the treatment of gastroesophageal reflux disease (GERD) and become the most powerful class of drugs to treat the disease. this. In today's article, we will discuss treatment-resistant reflux esophagitis, the definition of its clinical features, and the treatment response to PPIs.

Since entering the market, proton pump inhibitors (PPIs) have revolutionized the treatment of gastroesophageal reflux disease (GERD) and become the most powerful class of drugs to treat the disease. this. In today's article, we will discuss treatment-resistant reflux esophagitis, the definition of its clinical features, and the treatment response to PPIs.